Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy Children

This publication has 16 references indexed in Scilit:

• Estimating Efficacy of Trivalent, Cold-adapted, Influenza Virus Vaccine (CAIV-T) against Influenza A (H1N1) and B Using Surveillance Cultures
  American Journal of Epidemiology, 2003
• Safety and effectiveness of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children
  International Congress Series, 2001
• Burden of Disease—Implications for Future Research
  JAMA, 2001
• Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control
  Vaccine, 2000
• Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
  The Journal of Pediatrics, 2000
• Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
  New England Journal of Medicine, 2000
• The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children
  New England Journal of Medicine, 2000
• Effectiveness of Live, Attenuated Intranasal Influenza Virus Vaccine in Healthy, Working Adults
  JAMA, 1999
• Design and Interpretation of Vaccine Field Studies
  Epidemiologic Reviews, 1999
• Emerging Infections: Pandemic Influenza
  Epidemiologic Reviews, 1996